Details for Patent: 12,097,183
✉ Email this page to a colleague
Which drugs does patent 12,097,183 protect, and when does it expire?
Patent 12,097,183 protects ZEMBRACE SYMTOUCH and is included in one NDA.
This patent has six patent family members in six countries.
Summary for Patent: 12,097,183
| Title: | Pharmaceutical composition for treating migraine |
| Abstract: | The present application relates to a method of treating migraine or cluster headache in a human patient, said method comprising administering subcutaneously composition comprising sumatriptan or its pharmaceutically acceptable salt, in an amount equivalent to 3 mg sumatriptan base. |
| Inventor(s): | Prabhu Prabhakara, Rajesh Ramesh Patil, Piyush Gupta, Rajeev Singh Raghuvanshi, Anil N. Namboodiripad |
| Assignee: | Tonix Medicines Inc |
| Application Number: | US17/833,105 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 12,097,183
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tonix Meds | ZEMBRACE SYMTOUCH | sumatriptan succinate | SOLUTION;SUBCUTANEOUS | 208223-001 | Jan 28, 2016 | RX | Yes | No | 12,097,183 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,097,183
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Brazil | 112018002433 | ⤷ Start Trial | |||
| Canada | 2994748 | ⤷ Start Trial | |||
| China | 107921023 | ⤷ Start Trial | |||
| European Patent Office | 3331524 | ⤷ Start Trial | |||
| Mexico | 2018001528 | ⤷ Start Trial | |||
| World Intellectual Property Organization (WIPO) | 2017023361 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
